96 results

• Byetta, Januvia Pancreatic Cancer Plaintiffs Facing Death Can Testify Early

  November 14, 2013

  Austin Kirk

  In the federal MDL, plaintiffs facing end of life from pancreatic cancer may preserve testimony for trial by noticing an In Extremis deposition.

• Byetta, Januvia Attorneys Assigned to Leadership Roles in Federal MDL

  October 24, 2013

  Austin Kirk

  Attorneys have been appointed to leadership roles as incretin mimetic pancreatic cancer lawsuits move forward.

• Lawyers Seek Leadership Roles in Byetta, Januvia Cancer Litigation

  October 11, 2013

  Austin Kirk

  Attorneys seek leadership roles in MDL established for Byetta, Victoza, Janumet and Januvia lawsuits.

• Initial Conference Scheduled in MDL for Byetta, Januvia Cancer Lawsuits

  September 27, 2013

  Austin Kirk

  Lawyers involved in the pancreatic cancer lawsuits involving Byetta, Januvia, Janumet and Victoza are scheduled to meet with MDL judge on October 17.

• Sulphonylurea Diabetes Drugs May Increase Heart Attack Risk: Study

  September 19, 2013

  Irvin Jackson

  An older class of diabetes drugs has been linked to heart problems following a clincal study to confirm long-held fears.

• Byetta, Januvia Cancer Lawsuits Consolidated in California Federal Court

  August 27, 2013

  Austin Kirk

  All Byetta, Januvia, Janumet and Victoza lawsuits over pancreatic cancer have been consolidated as part of a single MDL in California federal court.

• Byetta, Januvia Lawsuits Over Pancreatic Cancer Continue to Roll In

  August 20, 2013

  Irvin Jackson

  Lawsuits against Byetta, Januvia and similar drugs continue to roll in despite FDA questions over links to pancreatic cancer.

• Novo Nordisk Sales Remain Strong, Even Amid Victoza Cancer Concerns

  August 12, 2013

  Irvin Jackson

  Victoza sales are on the rise despite calls for the diabetes drug to be recalled amid concerns of acute pancreatitis and pancreatic cancer.

• FDA Finds No Pancreatic Cancer Risk in Byetta, Januvia

  August 1, 2013

  Irvin Jackson

  The FDA says it can find no link between diabetes drugs like Byetta and Januvia and pancreatic cancer claims.

• Byetta, Januvia Pancreatic Cancer Review Results in No Change for EMA

  July 30, 2013

  Irvin Jackson

  European reviewers say they can find no evidence of an increased pancreatic cancer risk with Byetta, Januvia, Janumet and Victoza, but say some risk could still exist.